maj . 26, 2025 07:25 Back to list
(albendazole tablets for worms)
Albendazole tablets are a cornerstone in treating parasitic worm infections, including gastrointestinal nematodes and tissue-invasive helminths. With over 1.5 billion people affected globally by soil-transmitted helminthiases (WHO, 2023), this broad-spectrum anthelmintic addresses both individual and community health challenges. Its versatility spans single-dose regimens for stomach worms to prolonged courses for systemic parasites, making it a first-line option in clinical and public health settings.
Albendazole disrupts microtubule synthesis in helminths through selective binding to β-tubulin, causing energy depletion and paralysis. Clinical trials demonstrate a 92-97% cure rate against Ascaris lumbricoides and 76-88% efficacy against hookworms (NIH, 2022). The tablet's lipophilic nature enhances tissue penetration, achieving therapeutic concentrations in cysts, liver, and lungs—critical for treating hydatid disease and neurocysticercosis.
Brand | Dosage Form | Price/Tablet (USD) | Cure Rate (%) | Adverse Events (%) |
---|---|---|---|---|
Brand A | 400mg Chewable | $0.18 | 94 | 8.2 |
Brand B | 200mg Dispersible | $0.22 | 89 | 12.1 |
Brand C | 400mg Film-Coated | $0.15 | 91 | 9.8 |
A mass drug administration in Kenya reduced hookworm prevalence from 32% to 9% within 18 months using albendazole tablets (MOH Kenya, 2021). In India, a hospital-based study showed 94% resolution of hydatid cysts with 28-day albendazole therapy combined with imaging monitoring.
Transient abdominal pain (14%) and headache (6%) are common but self-limiting. Severe hepatotoxicity occurs in <0.1% of cases. The 400mg tablet's small size and neutral taste improve adherence compared to bulkier anthelmintics, with 89% completion rates in supervised programs.
Next-generation formulations aim to enhance bioavailability through nanoparticle carriers, with early trials showing 40% higher plasma concentrations. Combination therapies with ivermectin are under investigation for resistant strains, while chewable pediatric versions could expand access to 220 million untreated children (Global Health Initiative, 2023).
(albendazole tablets for worms)
A: Albendazole tablets are anthelmintic medications used to treat parasitic worm infections, including intestinal worms and stomach worms. They work by preventing the worms from absorbing nutrients, leading to their elimination.
A: Follow your doctor’s instructions, typically taking the tablet with food to improve absorption. Dosage depends on the type of infection, and treatment may require a single dose or a course over several days.
A: Common side effects include stomach pain, dizziness, or nausea. Severe reactions like allergic rash or liver issues are rare; consult a doctor if they occur.
A: Yes, but dosage is adjusted based on the child’s weight and age. Always consult a healthcare provider before administering albendazole to children under 2 years old.
A: Availability varies by country—some regions require a prescription, while others sell it over-the-counter. Check local regulations or consult a pharmacist for guidance.
Products categories